Pharma News – MSN Group receives US FDA APPROVAL for BUMETANIDE Injection, ANDA

MSN Group is pleased to announce that we received USFDA APPROVAL for BUMETANIDE Injection, ANDA 1 mg/4 mL (0.25 mg/mL) Single-Dose Vials & 2.5 mg/10 mL (0.25 mg/mL) Multiple-Dose Vials. REGULATORY APPROVALS UPDATE MSN Group receives US FDA APPROVAL for BUMETANIDE Injection, ANDA 1 mg/4 ml (0.25 mg/mL) Single-Dose Vials & 2.5 mg/10 ml (0.25 …

Pharma News – MSN Group receives US FDA APPROVAL for BUMETANIDE Injection, ANDA Apply Now✓